About LumaCyte

LumaCyte’s mission is to provide developers and manufacturer scientists with transformational analytical tools that accelerate medical and biopharmaceutical discoveries through novel cellular process analytics and characterization. Our vision is to empower scientists to ask questions and seek answers without the bias of antibodies or labels. Our cell analysis philosophy is based on the transformational power of measuring the native response of a cell to its environment, and the ability to detect subtle changes in biochemical and biophysical properties that deliver profound insights. At LumaCyte, we are passionate about transforming the status quo.

LumaCyte, Inc. is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytology™ (LFC) to measure optical and fluidic forces within a microfluidic channel, quantitatively characterizing innate cellular responses of subtle phenotypic changes based purely on the intrinsic biophysical and biochemical properties of cells; which can be used to measure cellular changes in response to their environment or treatment. The univariate and multivariate nature of the data has enabled a host of big data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCyte’s label-free platform technology include viral infectivity for vaccine development and manufacturing, cell health, activation, transfection and transduction analytics for cell and gene therapy development and production monitoring, CAR T-cell immunotherapy, iPSC differentiation, adventitious agent testing (AAT), infectious disease, and pre-clinical drug discovery, in addition to multiple applications across advanced therapy biomanufacturing for real-time quality control.